Sally E. Riggs, DClinPsy is a licensed psychologist and expert in Cognitive Behavioral Therapy for psychosis with 17 years of experience working in this field in both London, UK and the US. She earned her Doctorate in clinical psychology at Royal Holloway, University of London, UK in 2005, during which time she was trained in CBTp. She completed her Postdoctoral Research Fellowship at the Aaron T. Beck Psychopathology Research Unit, University of Pennsylvania, working on a pilot study for CBT for negative symptoms, and pioneering training in CBTp in community mental health agencies. She moved to NYC in 2011 to work at NYC Health + Hospitals/Kings County, initially on the adult inpatient service, and then as the lead psychologist in the adult outpatient department. During this time, she pioneered CBT for psychosis services at the hospital, both on the specialist early psychosis inpatient unit and throughout the outpatient clinics, training and supervising staff. In 2015 she joined Cognitive Behavioral Consultants, a group of internationally recognized mental health professionals who have researched, pioneered, and are highly experienced in delivering cutting edge treatments, bringing CBT to psychosis to their treatment modalities. In 2016 she founded NYC CBTp, the first ever private practice group dedicated to providing evidence based cognitive behavioral therapy for people with psychosis, as well as training and consultation for mental health professionals. She has been an invited member of the Annual International CBT for Psychosis Research Meeting since 2009, and is a Founding Member and current President of the North American CBT for psychosis Network.
Jennifer Gottlieb, Ph.D. is a Diplomate in the Academy of Cognitive Therapy and a licensed clinical psychologist, whose research and clinical work is dedicated to the development and implementation of effective psychotherapeutic interventions for psychosis, schizophrenia, and other severe psychiatric conditions. A member of the Aaron T. Beck International CBT for Psychosis Clinical Research Group, Dr. Gottlieb has provided CBTp clinical training, consultation, supervision, treatment implementation guidance (as well as training in clinical supervision provision) to therapists and administrators at numerous mental health agencies locally, nationally, and internationally. Specific foci include: the development and evaluation of CBT treatments for schizophrenia; novel interventions for first-episode and early psychosis; and specialized CBT treatments for PTSD in severe psychiatric conditions. She has been on the faculty at Massachusetts General Hospital/ Harvard Medical School Dept. of Psychiatry Schizophrenia Program, Dartmouth Medical School, and most recently at Boston University. She has extensive direct clinical CBTp experience with first-episode, early, and later-stage psychosis, as well as in the provision of interventions to treat PTSD, dual disorders, smoking, and social skills training, all within vulnerable populations. A fluent Spanish speaker, Dr. Gottlieb recently received a Fulbright Senior Researcher Award to Spain where she adapted and began implementation of the specialty CBT for PTSD intervention for severe psychiatric conditions.
Sarah Kopelovich, PhD is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences in the University of Washington School of Medicine and holds an endowed professorship in Cognitive Behavioral Therapy for psychosis (CBTp). Dr. Kopelovich is a licensed clinical psychologist with formal education and training in serious mental illness and forensic psychology. For the past 10 years, she has administered and supervised the provision of evidence-based psychotherapeutic interventions (EBPIs) as well as standardized psychological, risk, neurocognitive, and psychodiagnostic assessments of individuals with serious mental illness (SMI) in diverse settings and from diverse sociocultural backgrounds in New York, California, Georgia, and Washington. Since joining the faculty at the Center for Evidence Based Practices for Adults at the University of Washington in 2015, Dr. Kopelovich has served as the Principal Investigator (PI) and co-investigator on state- and foundation-funded projects aimed at implementing and disseminating EBPIs for schizophrenia spectrum disorders in outpatient, inpatient, Assertive Community Treatment, and forensic settings. Dr. Kopelovich has PI’d two multiyear CBTp workforce development initiatives that have resulted in more than 140 CBTp-trained providers across Washington State, the first Extension for Community Healthcare Outcomes (ECHO) Clinic focused on the treatment of psychosis, a CBTp Train-the-Trainer curriculum, and the first-in-the-nation CBTp Stepped Care program (http://depts.washington.edu/ebpa/projects/cbtp).
David Kimhy, PhD is an Associate Professor, the Director of the Experimental Psychopathology Laboratory, and the Program Leader for New Interventions in Schizophrenia at the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai. He also serve as a researcher at the Mental Illness Research, Education, and Clinical Center (MIRECC) at the James J. Peters VA Medical Center in The Bronx, NY. Prior to joining Mount Sinai in 2017, he was on faculty at Columbia University and the New York State Psychiatric Institute. Over the past decade, Dr. Kimhy served as a Beck Institute Scholar at the Beck Institute for Cognitive Therapy and Research and is a senior faculty at the Institute of Cognitive Therapy for Psychosis (ICTP), an institution dedicated to CBTp training and dissemination. Dr. Kimhy’s research center on two primary areas: 1) The use of translational approaches to elucidate the mechanisms of development and recovery from psychopathology in individuals with schizophrenia and at-risk for psychosis; and 2) The development and dissemination of cognitive and behavioral interventions to improve cognitive, affective, and social functioning. Dr. Kimhy served as a PI on multiple grants (R01, K23, R21, T32) funded by the National Institute of Mental Health (NIMH) and the National Alliance for Research of Schizophrenia and Affective Disorders (NARSAD).
Mahesh Menon, PhD is a Clinical Associate Professor in the Department of Psychiatry at the University of British Columbia. He is also a registered clinical psychologist, based at the UBC Hospital in the BC Psychosis Program, which is a specialized provincial program for individuals with treatment resistant psychosis. Dr. Menon completed his PhD at the University of Cambridge, and a postdoctoral fellowship at the Centre for Addiction & Mental Health/ University of Toronto. He also has an active research program, with a particular focus on understanding the cognitive mechanisms and brain networks associated with the symptoms of psychosis (particularly delusions), as well the role of psychotherapy in improving these symptoms. He has been involved with the ongoing development of metacognitive training for psychosis (MCT). His research has been funded by the Canadian Institute of Health Research (CIHR), the Ontario Mental Health Foundation (OMHF), The MIND Foundation, the Vancouver Coastal Health Research Institute (VCHRI), and NARSAD.
Harry J. Sivec, PhD is a clinical psychologist with extensive experience working with individuals with severe and persistent mental illness. Dr. Sivec earned his Ph.D. in clinical psychology from the Ohio University. He currently works as a consultant and trainer for the Best Practices in Schizophrenia Treatment (BeST) Center at the Northeast Ohio Medical University’s (NEOMED) Department of Psychiatry. The mission of the BeST Center is to expand access to evidence-based practices for individuals with schizophrenia and their family members. Dr. Sivec provides training and consultation services to a wide range of mental health providers and community agencies in Cognitive Behavioral Therapy for psychosis. He also provides both individual and group based interventions for individuals who experience psychosis. Dr. Sivec serves as a consulting editor for the APA journal Psychotherapy. Dr. Sivec is a clinical associate professor in the Department of Psychiatry at Northeast Ohio Medical University and an adjunct assistant professor in the Department of Psychological Sciences at Case Western Reserve University.
Training and Accreditation Subcommittee
Tania Lecomte, PhD is a full professor in the Department of Psychology at the University of Montreal and coordinator of the Treatment and Services division of research centre of the IUSMM. Her research projects focus on improving treatment for people with severe mental illness, either by creating new treatments, evaluating needs or training mental health workers. She has collaborated on creating and validating group interventions in cognitive behaviour therapy to improve self-esteem, work tenure, romantic relationships, and the symptoms of people suffering from psychoses. Her current research bears mainly on first-episode patients, but she is also interested in individuals with longer clinical histories. Her current work focuses on social cognition, comorbidities in individuals with psychosis (substance misuse, social anxiety, depression, personality disorders), CBT for supported employment, implementation issues regarding CBTp, as well as resilience, and fighting social isolation and loneliness. She is also interested in the stigmatization of psychosis and knowledge transfer in the community.
Nicola Wright, PhD is a clinical psychologist on The Schizophrenia Program of the Royal Ottawa Health Care Group (ROHCG), Canada. Dr. Wright engages in individual and group cognitive behavioral therapy for people who experience psychosis (CBTP). She is a clinical professor with the school of psychology at the University of Ottawa. Given her passion for training and education, she was president of the Canadian Council of Professional Psychology Programs and has served on both the Accreditation Panel, and the Education and Training committee of the Canadian Psychological Association. Dr. Wright is a founding member of the Canadian Association of Cognitive Behavioral Therapy. She is the lead author of the book Treating Psychosis: A Clinician’s Guide to integrating Acceptance and Commitment Therapy, Compassion-focused Therapy and Mindfulness approaches within the Cognitive Behavioral Therapy Tradition (Wright et al., 2014). She is the principle investigator of two University of Ottawa medical research fund grants on randomized controlled trials for group CBT for Psychosis and group CBT for Voices. She conducts supervision for the Beck Institute and presents training workshops on CBT for Psychosis. She believes passionately in an empowering recovery-oriented CBT approach to working with those who experience psychosis.
Corinne Cather, PhD is an Assistant Professor of Psychology at Harvard Medical School and the Director of Psychology Services for the Schizophrenia Clinical and Research Program at the Massachusetts General Hospital Schizophrenia Program in Boston. Dr. Cather earned her undergraduate degree in biopsychology at Hamilton College in Clinton, NY and her doctorate in clinical psychology from Rutgers University, where she received specialized training in cognitive behavioral therapy (CBT) and behavioral medicine. She completed an internship at the University of Medicine and Dentistry of New Jersey and joined the Schizophrenia Clinical and Research Program as a post-doctoral fellow in 1999. She has extensive experience as a clinician-researcher with first episode/early psychosis as well as with chronic schizophrenia, and she has developed an international reputation as one of the few practitioners in the US to study and train in cognitive behavioral therapy in schizophrenia. She served as a consultant on the NIMH RAISE project designed to disseminate training in state-of-the-art multi-component first episode treatment and was responsible for developing the individual and family intervention manuals around preventing and responding to weight gain and smoking cessation for this project.
Faye Doell, PhD is a registered psychologist who received her doctoral degree in Clinical Psychology from York University. Dr. Doell currently holds a position as Clinical Lead of the CBT for Psychosis Service in the Complex Care & Recovery Program at the Centre for Addiction and Mental Health (CAMH). In this role, she has been responsible for developing group and individual programming in CBTp, providing leadership for capacity building initiatives, and establishing a comprehensive training program in CBT for psychosis for students, residents and staff at CAMH. Dr. Doell is also an adjunct faculty member at York University, where she has previously taught several undergraduate courses and provided supervision to graduate student therapists in the York University Psychology Clinic. In addition, she is a member of the Motivational Interviewing Network of Trainers, and she provides training to professionals who are interested in learning motivational interviewing. Dr. Doell’s clinical experience includes work and training with a wide range of treatment approaches and client populations, with an emphasis on treating adults suffering with severe and persistent mental illness.
Sarah Kopelovich, PhD (please see biosketch for Communications Officer)
Kate Hardy, Clin.Psych.D is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 15 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. She has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population.